Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Schachter

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|January 22, 2014
Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?Sheila K West, Jeanne Moncada, Beatriz Munoz, et al.
Sexually Transmitted Diseases|April 27, 2004
The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluationJeanne Moncada, Julius Schachter, Edward W Hook, et al.
BMC Infectious Diseases|November 19, 2015
What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinionNicole H T M Dukers-Muijrers, Julius Schachter, Genevieve A F S van Liere, et al.
Emerging Infectious Diseases|December 2, 2005
Slow epidemic of lymphogranuloma venereum L2b strainJoke Spaargaren, Julius Schachter, Jeanne Moncada, et al.
Sexually Transmitted Diseases|November 30, 2005
Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infectionsJulius Schachter, Max A Chernesky, Dean E Willis, et al.
Preventive Medicine|November 9, 2004
Evaluation of a cognitive-behavioral, group, randomized controlled intervention trial to prevent sexually transmitted infections and unintended pregnancies in young womenCherrie B Boyer, Mary-Ann Shafer, Richard A Shaffer, et al.
Emerging Infectious Diseases|May 10, 2003
Eliminating trachoma in areas with limited diseaseBruce D Gaynor, Yinghui Miao, Vicky Cevallos, et al.
Ophthalmic Epidemiology|August 21, 2002
Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?Jocelyn Thein, Puning Zhao, Hansheng Liu, et al.
The British Journal of Ophthalmology|October 20, 2006
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachomaJon L Yang, Julius Schachter, Jeanne Moncada, et al.
Plos Neglected Tropical Diseases|December 20, 2011
Risk factors for ocular chlamydia after three mass azithromycin distributionsBerhan Ayele, Teshome Gebre, Jeanne Moncada, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|January 22, 2014
Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?Sheila K West, Jeanne Moncada, Beatriz Munoz, et al.
Sexually Transmitted Diseases|April 27, 2004
The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluationJeanne Moncada, Julius Schachter, Edward W Hook, et al.
BMC Infectious Diseases|November 19, 2015
What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinionNicole H T M Dukers-Muijrers, Julius Schachter, Genevieve A F S van Liere, et al.
Emerging Infectious Diseases|December 2, 2005
Slow epidemic of lymphogranuloma venereum L2b strainJoke Spaargaren, Julius Schachter, Jeanne Moncada, et al.
Sexually Transmitted Diseases|November 30, 2005
Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infectionsJulius Schachter, Max A Chernesky, Dean E Willis, et al.
Preventive Medicine|November 9, 2004
Evaluation of a cognitive-behavioral, group, randomized controlled intervention trial to prevent sexually transmitted infections and unintended pregnancies in young womenCherrie B Boyer, Mary-Ann Shafer, Richard A Shaffer, et al.
Emerging Infectious Diseases|May 10, 2003
Eliminating trachoma in areas with limited diseaseBruce D Gaynor, Yinghui Miao, Vicky Cevallos, et al.
Ophthalmic Epidemiology|August 21, 2002
Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?Jocelyn Thein, Puning Zhao, Hansheng Liu, et al.
The British Journal of Ophthalmology|October 20, 2006
Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachomaJon L Yang, Julius Schachter, Jeanne Moncada, et al.
Plos Neglected Tropical Diseases|December 20, 2011
Risk factors for ocular chlamydia after three mass azithromycin distributionsBerhan Ayele, Teshome Gebre, Jeanne Moncada, et al.
Pageof 7